» Articles » PMID: 11979253

Intraductal Papillary Mucinous Tumor of the Pancreas

Overview
Date 2002 Apr 30
PMID 11979253
Citations 17
Authors
Affiliations
Soon will be listed here.
Citing Articles

Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.

Das K, Geng X, Brown J, Morales-Oyarvide V, Huynh T, Pergolini I Gastroenterology. 2019; 157(3):720-730.e2.

PMID: 31175863 PMC: 6707850. DOI: 10.1053/j.gastro.2019.05.014.


Successful management of life-threatening bleeding of intraductal papillary mucinous neoplasms in the pancreatic head.

Tokue H, Morita H, Tokue A, Tsushima Y SAGE Open Med Case Rep. 2017; 5:2050313X17741014.

PMID: 29163954 PMC: 5686876. DOI: 10.1177/2050313X17741014.


Expansion of epigenetic alterations in EFEMP1 promoter predicts malignant formation in pancreatobiliary intraductal papillary mucinous neoplasms.

Yoshida K, Nagasaka T, Umeda Y, Tanaka T, Kimura K, Taniguchi F J Cancer Res Clin Oncol. 2016; 142(7):1557-69.

PMID: 27095449 PMC: 4899496. DOI: 10.1007/s00432-016-2164-x.


Diagnosis and management of cystic lesions of the pancreas.

Brugge W J Gastrointest Oncol. 2015; 6(4):375-88.

PMID: 26261724 PMC: 4502158. DOI: 10.3978/j.issn.2078-6891.2015.057.


Adrenal pseudocyst mimicking cystic neoplasm of pancreatic tail.

Marwah S, Marwah N, Garg S, Mathur S Clin J Gastroenterol. 2015; 4(4):262-265.

PMID: 26189531 DOI: 10.1007/s12328-011-0231-z.